Search Within


Applied Filters:
Showing 1-2 of 2 results for "333-20-0" within Papers
Matthew Hoffmann et al.
Xenobiotica; the fate of foreign compounds in biological systems, 41(12), 1063-1075 (2011-08-24)
Apremilast is a novel, orally available small molecule that specifically inhibits PDE4 and thus modulates multiple pro- and anti-inflammatory mediators, and is currently under clinical development for the treatment of psoriasis and psoriatic arthritis. The pharmacokinetics and disposition of [(14)C]apremilast
Ronald Klein et al.
JAMA ophthalmology, 131(3), 383-392 (2013-03-16)
To describe the relationships of risk alleles in complement factor H (CFH, rs1061170) and age-related maculopathy susceptibility 2 (ARMS2, rs10490924) to the incidence and progression of age-related macular degeneration (AMD) during a 20-year period. There were 4282 persons aged 43
Page 1 of 1